This post was originally published on this site
Medtronic announced earnings per share of $1.02 on revenue of $7.65B. Analysts polled by Investing.com anticipated EPS of $0.8024 on revenue of $7.07B.
Medtronic shares are down 2% from the beginning of the year, still down 9.15% from its 52 week high of $122.15 set on January 22. They are under-performing the S&P 500 which is up 10.73% from the start of the year.
Medtronic’s report follows an earnings beat by Merck&Co on October 27, who reported EPS of $1.74 on revenue of $12.55B, compared to forecasts EPS of $1.44 on revenue of $12.21B.
Pfizer had beat expectations on October 27 with third quarter EPS of $0.6821 on revenue of $12.13B, compared to forecast for EPS of $0.6762 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
